Persistent expression of CD26/DPPIV after treatment with infliximab in psoriasis despite clinical improvement. [electronic resource]
Producer: 20091112Description: 518-20 p. digitalISSN:- 1651-2057
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Biopsy
- Dermatologic Agents -- therapeutic use
- Dipeptidyl Peptidase 4 -- metabolism
- Female
- Humans
- Infliximab
- Keratinocytes -- drug effects
- Male
- Middle Aged
- Psoriasis -- drug therapy
- Severity of Illness Index
- T-Lymphocytes -- drug effects
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Letter
There are no comments on this title.
Log in to your account to post a comment.